Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 251

1.

Gene Correction of LGMD2A Patient-Specific iPSCs for the Development of Targeted Autologous Cell Therapy.

Selvaraj S, Dhoke NR, Kiley J, Mateos-Aierdi AJ, Tungtur S, Mondragon-Gonzalez R, Killeen G, Oliveira VKP, López de Munain A, Perlingeiro RCR.

Mol Ther. 2019 Aug 28. pii: S1525-0016(19)30394-6. doi: 10.1016/j.ymthe.2019.08.011. [Epub ahead of print]

PMID:
31501033
2.

Parkinsonism and spastic paraplegia type 7: Expanding the spectrum of mitochondrial Parkinsonism.

De la Casa-Fages B, Fernández-Eulate G, Gamez J, Barahona-Hernando R, Morís G, García-Barcina M, Infante J, Zulaica M, Fernández-Pelayo U, Muñoz-Oreja M, Urtasun M, Olaskoaga A, Zelaya V, Jericó I, Saez-Villaverde R, Catalina I, Sola E, Martínez-Sáez E, Pujol A, Ruiz M, Schlüter A, Spinazzola A, Muñoz-Blanco JL, Grandas F, Holt I, Álvarez V, López de Munaín A.

Mov Disord. 2019 Aug 21. doi: 10.1002/mds.27812. [Epub ahead of print]

PMID:
31433872
3.

Age-related cognitive decline in myotonic dystrophy type 1: An 11-year longitudinal follow-up study.

Labayru G, Aliri J, Zulaica M, López de Munain A, Sistiaga A.

J Neuropsychol. 2019 Aug 13. doi: 10.1111/jnp.12192. [Epub ahead of print]

PMID:
31407859
4.

Study of the effect of anti-rhGAA antibodies at low and intermediate titers in late onset Pompe patients treated with ERT.

Fernández-Simón E, Carrasco-Rozas A, Gallardo E, González-Quereda L, Alonso-Pérez J, Belmonte I, Pedrosa-Hernández I, Montiel E, Segovia S, Suárez-Calvet X, Llauger J, Mayos M, Illa I, Barba-Romero MA, Barcena J, Paradas C, Carzorla MR, Creus C, Coll-Cantí J, Díaz M, Domínguez C, Fernández-Torrón R, García-Antelo MJ, Grau JM, López de Munáin A, Martínez-García FA, Morgado Y, Moreno A, Morís G, Muñoz-Blanco MA, Nascimento A, Parajuá-Pozo JL, Querol L, Rojas R, Robledo-Strauss A, Rojas-Marcos Í, Salazar JA, Usón M, Díaz-Manera J.

Mol Genet Metab. 2019 Jul 23. pii: S1096-7192(18)30784-4. doi: 10.1016/j.ymgme.2019.07.013. [Epub ahead of print]

PMID:
31378569
5.

Nonsense mutations in alpha-II spectrin in three families with juvenile onset hereditary motor neuropathy.

Beijer D, Deconinck T, De Bleecker JL, Dotti MT, Malandrini A, Urtizberea JA, Zulaica M, López de Munain A, Asselbergh B, De Jonghe P, Baets J.

Brain. 2019 Sep 1;142(9):2605-2616. doi: 10.1093/brain/awz216.

PMID:
31332438
6.

Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia.

Clos-Garcia M, Andrés-Marin N, Fernández-Eulate G, Abecia L, Lavín JL, van Liempd S, Cabrera D, Royo F, Valero A, Errazquin N, Vega MCG, Govillard L, Tackett MR, Tejada G, Gónzalez E, Anguita J, Bujanda L, Orcasitas AMC, Aransay AM, Maíz O, López de Munain A, Falcón-Pérez JM.

EBioMedicine. 2019 Aug;46:499-511. doi: 10.1016/j.ebiom.2019.07.031. Epub 2019 Jul 18.

7.

Spanish Pompe registry: Baseline characteristics of first 49 patients with adult onset of Pompe disease.

Alonso-Pérez J, Segovia S, Domínguez-González C, Olivé M, Mendoza Grimón MD, Fernández-Torrón R, López de Munain A, Muñoz-Blanco JL, Ramos-Fransi A, Almendrote M, Illa I, Díaz-Manera J.

Med Clin (Barc). 2019 Jun 25. pii: S0025-7753(19)30346-X. doi: 10.1016/j.medcli.2019.03.036. [Epub ahead of print] English, Spanish.

PMID:
31253477
8.

FAHN/SPG35: a narrow phenotypic spectrum across disease classifications.

Rattay TW, Lindig T, Baets J, Smets K, Deconinck T, Söhn AS, Hörtnagel K, Eckstein KN, Wiethoff S, Reichbauer J, Döbler-Neumann M, Krägeloh-Mann I, Auer-Grumbach M, Plecko B, Münchau A, Wilken B, Janauschek M, Giese AK, De Bleecker JL, Ortibus E, Debyser M, Lopez de Munain A, Pujol A, Bassi MT, D'Angelo MG, De Jonghe P, Züchner S, Bauer P, Schöls L, Schüle R.

Brain. 2019 Jun 1;142(6):1561-1572. doi: 10.1093/brain/awz102.

PMID:
31135052
9.

Author Correction: A new approach based on targeted pooled DNA sequencing identifies novel mutations in patients with Inherited Retinal Dystrophies.

Ezquerra-Inchausti M, Anasagasti A, Barandika O, Garay-Aramburu G, Galdós M, López de Munain A, Irigoyen C, Ruiz-Ederra J.

Sci Rep. 2019 May 28;9(1):8113. doi: 10.1038/s41598-019-44425-7.

10.

Isolation and characterization of myogenic precursor cells from human cremaster muscle.

Naldaiz-Gastesi N, Goicoechea M, Aragón IM, Pérez-López V, Fuertes-Alvarez S, Herrera-Imbroda B, López de Munain A, de Luna-Diaz R, Baptista PM, Fernández MA, Lara MF, Izeta A.

Sci Rep. 2019 Mar 5;9(1):3454. doi: 10.1038/s41598-019-40042-6.

11.

[Extensive encephalomyelitis due to Borrelia: an atypical form of neuroborreliosis].

Campo-Caballero D, Munoz-Lopetegi A, Fernandez-Garcia de Eulate G, Rodriguez-Antiguedad J, Gabilondo A, Gonzalez F, Villanua J, Lopez de Munain A.

Rev Neurol. 2019 Feb 16;68(4):169-170. Spanish.

12.

Blood Markers in Healthy-Aged Nonagenarians: A Combination of High Telomere Length and Low Amyloidβ Are Strongly Associated With Healthy Aging in the Oldest Old.

Fernández-Eulate G, Alberro A, Muñoz-Culla M, Zulaica M, Zufiría M, Barandiarán M, Etxeberria I, Yanguas JJ, Gallardo MM, Soberón N, Lacosta AM, Pérez-Grijalba V, Canudas J, Fandos N, Pesini P, Sarasa M, Indakoetxea B, Moreno F, Vergara I, Otaegui D, Blasco M, López de Munain A.

Front Aging Neurosci. 2018 Nov 28;10:380. doi: 10.3389/fnagi.2018.00380. eCollection 2018.

13.

Participation in a population-based screening for colorectal cancer using the faecal immunochemical test decreases mortality in 5 years.

Idigoras Rubio I, Arana-Arri E, Portillo Villares I, Bilbao Iturribarrria I, Martínez-Indart L, Imaz-Ayo N, de la Cruz M, de Castro V, López de Munain A, Torrejón Perez I, Gutiérrez-Ibarluzea I.

Eur J Gastroenterol Hepatol. 2019 Feb;31(2):197-204. doi: 10.1097/MEG.0000000000001338.

PMID:
30543575
14.

Amyotrophic lateral sclerosis: a complex syndrome that needs an integrated research approach.

Riancho J, Gil-Bea FJ, Santurtun A, López de Munaín A.

Neural Regen Res. 2019 Feb;14(2):193-196. doi: 10.4103/1673-5374.244783. Review.

15.

Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy.

Alonso-Jimenez A, Kroon RHMJM, Alejaldre-Monforte A, Nuñez-Peralta C, Horlings CGC, van Engelen BGM, Olivé M, González L, Verges-Gil E, Paradas C, Márquez C, Garibaldi M, Gallano P, Rodriguez MJ, Gonzalez-Quereda L, Dominguez Gonzalez C, Vissing J, Fornander F, Eisum AV, García-Sobrino T, Pardo J, García-Figueiras R, Muelas N, Vilchez JJ, Kapetanovic S, Tasca G, Monforte M, Ricci E, Gomez MT, Bevilacqua JA, Diaz-Jara J, Zamorano II, Carlier RY, Laforet P, Pelayo-Negro A, Ramos-Fransi A, Martínez A, Marini-Bettolo C, Straub V, Gutiérrez G, Stojkovic T, Martín MA, Morís G, Fernández-Torrón R, Lopez De Munaín A, Cortes-Vicente E, Querol L, Rojas-García R, Illa I, Diaz-Manera J.

J Neurol Neurosurg Psychiatry. 2019 May;90(5):576-585. doi: 10.1136/jnnp-2018-319578. Epub 2018 Dec 8.

PMID:
30530568
16.

Longitudinal Neuropsychological Study of Presymptomatic c.709-1G>A Progranulin Mutation Carriers.

Barandiaran M, Moreno F, de Arriba M, Indakoetxea B, Boda I, Gabilondo A, Tainta M, López de Munain A.

J Int Neuropsychol Soc. 2019 Jan;25(1):39-47. doi: 10.1017/S1355617718000735. Epub 2018 Oct 29.

PMID:
30369339
17.

A new approach based on targeted pooled DNA sequencing identifies novel mutations in patients with Inherited Retinal Dystrophies.

Ezquerra-Inchausti M, Anasagasti A, Barandika O, Garay-Aramburu G, Galdós M, López de Munain A, Irigoyen C, Ruiz-Ederra J.

Sci Rep. 2018 Oct 18;8(1):15457. doi: 10.1038/s41598-018-33810-3. Erratum in: Sci Rep. 2019 May 28;9(1):8113.

18.

Social cognition in myotonic dystrophy type 1: Specific or secondary impairment?

Labayru G, Arenzana I, Aliri J, Zulaica M, López de Munain A, Sistiaga A A.

PLoS One. 2018 Sep 24;13(9):e0204227. doi: 10.1371/journal.pone.0204227. eCollection 2018.

19.

Retinoids and Amyotrophic Lateral Sclerosis.

Riancho J, Gil-Bea FJ, López de Munaín A.

JAMA Neurol. 2018 Sep 1;75(9):1153. doi: 10.1001/jamaneurol.2018.2242. No abstract available.

PMID:
30105376
20.

Impaired Mitophagy and Protein Acetylation Levels in Fibroblasts from Parkinson's Disease Patients.

Yakhine-Diop SMS, Niso-Santano M, Rodríguez-Arribas M, Gómez-Sánchez R, Martínez-Chacón G, Uribe-Carretero E, Navarro-García JA, Ruiz-Hurtado G, Aiastui A, Cooper JM, López de Munaín A, Bravo-San Pedro JM, González-Polo RA, Fuentes JM.

Mol Neurobiol. 2019 Apr;56(4):2466-2481. doi: 10.1007/s12035-018-1206-6. Epub 2018 Jul 21.

PMID:
30032424
21.

Cancer phenotype in myotonic dystrophy patients: Results from a meta-analysis.

Emparanza JI, López de Munain A, Greene MH, Matheu A, Fernández-Torrón R, Gadalla SM.

Muscle Nerve. 2018 Oct;58(4):517-522. doi: 10.1002/mus.26194.

PMID:
30028904
22.

The panniculus carnosus muscle: an evolutionary enigma at the intersection of distinct research fields.

Naldaiz-Gastesi N, Bahri OA, López de Munain A, McCullagh KJA, Izeta A.

J Anat. 2018 Jun 12. doi: 10.1111/joa.12840. [Epub ahead of print] Review.

PMID:
29893024
23.

Expression Profiling Analysis Reveals Key MicroRNA-mRNA Interactions in Early Retinal Degeneration in Retinitis Pigmentosa.

Anasagasti A, Ezquerra-Inchausti M, Barandika O, Muñoz-Culla M, Caffarel MM, Otaegui D, López de Munain A, Ruiz-Ederra J.

Invest Ophthalmol Vis Sci. 2018 May 1;59(6):2381-2392. doi: 10.1167/iovs.18-24091.

24.

Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.

Pottier C, Zhou X, Perkerson RB 3rd, Baker M, Jenkins GD, Serie DJ, Ghidoni R, Benussi L, Binetti G, López de Munain A, Zulaica M, Moreno F, Le Ber I, Pasquier F, Hannequin D, Sánchez-Valle R, Antonell A, Lladó A, Parsons TM, Finch NA, Finger EC, Lippa CF, Huey ED, Neumann M, Heutink P, Synofzik M, Wilke C, Rissman RA, Slawek J, Sitek E, Johannsen P, Nielsen JE, Ren Y, van Blitterswijk M, DeJesus-Hernandez M, Christopher E, Murray ME, Bieniek KF, Evers BM, Ferrari C, Rollinson S, Richardson A, Scarpini E, Fumagalli GG, Padovani A, Hardy J, Momeni P, Ferrari R, Frangipane F, Maletta R, Anfossi M, Gallo M, Petrucelli L, Suh E, Lopez OL, Wong TH, van Rooij JGJ, Seelaar H, Mead S, Caselli RJ, Reiman EM, Noel Sabbagh M, Kjolby M, Nykjaer A, Karydas AM, Boxer AL, Grinberg LT, Grafman J, Spina S, Oblak A, Mesulam MM, Weintraub S, Geula C, Hodges JR, Piguet O, Brooks WS, Irwin DJ, Trojanowski JQ, Lee EB, Josephs KA, Parisi JE, Ertekin-Taner N, Knopman DS, Nacmias B, Piaceri I, Bagnoli S, Sorbi S, Gearing M, Glass J, Beach TG, Black SE, Masellis M, Rogaeva E, Vonsattel JP, Honig LS, Kofler J, Bruni AC, Snowden J, Mann D, Pickering-Brown S, Diehl-Schmid J, Winkelmann J, Galimberti D, Graff C, Öijerstedt L, Troakes C, Al-Sarraj S, Cruchaga C, Cairns NJ, Rohrer JD, Halliday GM, Kwok JB, van Swieten JC, White CL 3rd, Ghetti B, Murell JR, Mackenzie IRA, Hsiung GR, Borroni B, Rossi G, Tagliavini F, Wszolek ZK, Petersen RC, Bigio EH, Grossman M, Van Deerlin VM, Seeley WW, Miller BL, Graff-Radford NR, Boeve BF, Dickson DW, Biernacka JM, Rademakers R.

Lancet Neurol. 2018 Jun;17(6):548-558. doi: 10.1016/S1474-4422(18)30126-1. Epub 2018 Apr 30.

25.

Acetylome in Human Fibroblasts From Parkinson's Disease Patients.

Yakhine-Diop SMS, Rodríguez-Arribas M, Martínez-Chacón G, Uribe-Carretero E, Gómez-Sánchez R, Aiastui A, López de Munain A, Bravo-San Pedro JM, Niso-Santano M, González-Polo RA, Fuentes JM.

Front Cell Neurosci. 2018 Apr 17;12:97. doi: 10.3389/fncel.2018.00097. eCollection 2018.

26.

Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation.

Madero-Pérez J, Fdez E, Fernández B, Lara Ordóñez AJ, Blanca Ramírez M, Gómez-Suaga P, Waschbüsch D, Lobbestael E, Baekelandt V, Nairn AC, Ruiz-Martínez J, Aiastui A, López de Munain A, Lis P, Comptdaer T, Taymans JM, Chartier-Harlin MC, Beilina A, Gonnelli A, Cookson MR, Greggio E, Hilfiker S.

Mol Neurodegener. 2018 Jan 23;13(1):3. doi: 10.1186/s13024-018-0235-y.

27.

[Patients organizations and new drug approval in the US. Eteplirsen and Duchenne muscular dystrophy case].

Dal-Ré R, Lopez de Munain A, Ayuso C.

Rev Neurol. 2017 Oct 16;65(8):373-380. Review. Spanish.

28.

Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis.

Gil-Bea FJ, Aldanondo G, Lasa-Fernández H, López de Munain A, Vallejo-Illarramendi A.

Expert Rev Mol Med. 2017 Jun 9;19:e7. doi: 10.1017/erm.2017.9. Review.

PMID:
28597807
29.

The unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: Clinical and pathological characteristics.

Moreno F, Indakoetxea B, Barandiaran M, Caballero MC, Gorostidi A, Calafell F, Gabilondo A, Tainta M, Zulaica M, Martí Massó JF, López de Munain A, Sánchez-Juan P, Lee SE.

PLoS One. 2017 Jun 8;12(6):e0178093. doi: 10.1371/journal.pone.0178093. eCollection 2017.

30.

iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology.

Matamoros-Angles A, Gayosso LM, Richaud-Patin Y, di Domenico A, Vergara C, Hervera A, Sousa A, Fernández-Borges N, Consiglio A, Gavín R, López de Maturana R, Ferrer I, López de Munain A, Raya Á, Castilla J, Sánchez-Pernaute R, Del Río JA.

Mol Neurobiol. 2018 Apr;55(4):3033-3048. doi: 10.1007/s12035-017-0506-6. Epub 2017 May 2.

31.

Progressive changes in non-coding RNA profile in leucocytes with age.

Muñoz-Culla M, Irizar H, Gorostidi A, Alberro A, Osorio-Querejeta I, Ruiz-Martínez J, Olascoaga J, López de Munain A, Otaegui D.

Aging (Albany NY). 2017 Apr;9(4):1202-1218. doi: 10.18632/aging.101220.

32.

Nontraditional Lipid Variables Predict Recurrent Brain Ischemia in Embolic Stroke of Undetermined Source.

de la Riva P, Zubikarai M, Sarasqueta C, Tainta M, Muñoz-Lopetegui A, Andrés-Marín N, González F, Díez N, de Arce A, Bergareche A, Lopez de Munain A, Martínez-Zabaleta M.

J Stroke Cerebrovasc Dis. 2017 Aug;26(8):1670-1677. doi: 10.1016/j.jstrokecerebrovasdis.2017.03.024. Epub 2017 Apr 13.

PMID:
28412318
33.

FRZB and melusin, overexpressed in LGMD2A, regulate integrin β1D isoform replacement altering myoblast fusion and the integrin-signalling pathway.

Jaka O, Casas-Fraile L, Azpitarte M, Aiastui A, López de Munain A, Sáenz A.

Expert Rev Mol Med. 2017 Mar 16;19:e2. doi: 10.1017/erm.2017.3.

PMID:
28300015
34.

Incidence of varicella zoster virus infections of the central nervous system in the elderly: a large tertiary hospital-based series (2007-2014).

Arruti M, Piñeiro LD, Salicio Y, Cilla G, Goenaga MA, López de Munain A.

J Neurovirol. 2017 Jun;23(3):451-459. doi: 10.1007/s13365-017-0519-y. Epub 2017 Feb 21.

PMID:
28224485
35.

High prevalence of mutations affecting the splicing process in a Spanish cohort with autosomal dominant retinitis pigmentosa.

Ezquerra-Inchausti M, Barandika O, Anasagasti A, Irigoyen C, López de Munain A, Ruiz-Ederra J.

Sci Rep. 2017 Jan 3;7:39652. doi: 10.1038/srep39652.

36.

Mutations in LRRK2 impair NF-κB pathway in iPSC-derived neurons.

López de Maturana R, Lang V, Zubiarrain A, Sousa A, Vázquez N, Gorostidi A, Águila J, López de Munain A, Rodríguez M, Sánchez-Pernaute R.

J Neuroinflammation. 2016 Nov 18;13(1):295.

37.

Dominant LGMD2A: alternative diagnosis or hidden digenism?

Sáenz A, López de Munain A.

Brain. 2017 Feb;140(2):e7. doi: 10.1093/brain/aww281. Epub 2016 Nov 5. No abstract available.

PMID:
27818383
38.

Association of lifestyle, inflammatory factors, and dietary patterns with the risk of suffering a stroke: A case-control study.

Abete I, Zulet MA, Goyenechea E, Blazquez V, de Arce Borda AM, Lopez de Munain A, Martinez JA.

Nutr Neurosci. 2018 Jan;21(1):70-78. doi: 10.1080/1028415X.2016.1226473. Epub 2016 Sep 7.

PMID:
27603597
39.

Identification and Characterization of the Dermal Panniculus Carnosus Muscle Stem Cells.

Naldaiz-Gastesi N, Goicoechea M, Alonso-Martín S, Aiastui A, López-Mayorga M, García-Belda P, Lacalle J, San José C, Araúzo-Bravo MJ, Trouilh L, Anton-Leberre V, Herrero D, Matheu A, Bernad A, García-Verdugo JM, Carvajal JJ, Relaix F, Lopez de Munain A, García-Parra P, Izeta A.

Stem Cell Reports. 2016 Sep 13;7(3):411-424. doi: 10.1016/j.stemcr.2016.08.002. Epub 2016 Sep 1.

40.

Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation.

Fernández-Torrón R, García-Puga M, Emparanza JI, Maneiro M, Cobo AM, Poza JJ, Espinal JB, Zulaica M, Ruiz I, Martorell L, Otaegui D, Matheu A, López de Munain A.

Neurology. 2016 Sep 20;87(12):1250-7. doi: 10.1212/WNL.0000000000003124. Epub 2016 Aug 24.

PMID:
27558368
41.

Genetic Mutation Analysis of Parkinson's Disease Patients Using Multigene Next-Generation Sequencing Panels.

Gorostidi A, Martí-Massó JF, Bergareche A, Rodríguez-Oroz MC, López de Munain A, Ruiz-Martínez J.

Mol Diagn Ther. 2016 Oct;20(5):481-91. doi: 10.1007/s40291-016-0216-1.

PMID:
27294386
42.

ALS: A bucket of genes, environment, metabolism and unknown ingredients.

Zufiría M, Gil-Bea FJ, Fernández-Torrón R, Poza JJ, Muñoz-Blanco JL, Rojas-García R, Riancho J, López de Munain A.

Prog Neurobiol. 2016 Jul;142:104-129. doi: 10.1016/j.pneurobio.2016.05.004. Epub 2016 May 26. Review.

PMID:
27236050
43.

Editorial: Role of Stem Cells in Skeletal Muscle Development, Regeneration, Repair, Aging, and Disease.

Muñoz-Cánoves P, Carvajal JJ, Lopez de Munain A, Izeta A.

Front Aging Neurosci. 2016 Apr 28;8:95. doi: 10.3389/fnagi.2016.00095. eCollection 2016. No abstract available.

44.

A Cost-Effective Mutation Screening Strategy for Inherited Retinal Dystrophies.

Barandika O, Irigoyen C, Anasagasti A, Egiguren G, Ezquerra-Inchausti M, López de Munain A, Ruiz-Ederra J.

Ophthalmic Res. 2016;56(3):123-31. doi: 10.1159/000445690. Epub 2016 May 5.

PMID:
27160245
45.

Natural history of LGMD2A for delineating outcome measures in clinical trials.

Richard I, Hogrel JY, Stockholm D, Payan CA, Fougerousse F; Calpainopathy Study Group, Eymard B, Mignard C, Lopez de Munain A, Fardeau M, Urtizberea JA.

Ann Clin Transl Neurol. 2016 Mar 4;3(4):248-65. doi: 10.1002/acn3.287. eCollection 2016 Apr.

46.

Calpain 3 deficiency affects SERCA expression and function in the skeletal muscle.

Toral-Ojeda I, Aldanondo G, Lasa-Elgarresta J, Lasa-Fernández H, Fernández-Torrón R, López de Munain A, Vallejo-Illarramendi A.

Expert Rev Mol Med. 2016 Apr 8;18:e7. doi: 10.1017/erm.2016.9.

47.

Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Type 1 Biomarkers.

Fernandez-Costa JM, Llamusi B, Bargiela A, Zulaica M, Alvarez-Abril MC, Perez-Alonso M, Lopez de Munain A, Lopez-Castel A, Artero R.

PLoS One. 2016 Feb 26;11(2):e0150501. doi: 10.1371/journal.pone.0150501. eCollection 2016.

48.

SncRNA (microRNA &snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent.

Muñoz-Culla M, Irizar H, Sáenz-Cuesta M, Castillo-Triviño T, Osorio-Querejeta I, Sepúlveda L, López de Munain A, Olascoaga J, Otaegui D.

Sci Rep. 2016 Feb 1;6:20126. doi: 10.1038/srep20126.

49.

DAT imaging and clinical biomarkers in relatives at genetic risk for LRRK2 R1441G Parkinson's disease.

Bergareche A, Rodríguez-Oroz MC, Estanga A, Gorostidi A, López de Munain A, Castillo-Triviño T, Ruiz-Martínez J, Mondragón E, Gaig C, Lomeña F, Sarasqueta C, Tolosa E, Martí-Massó JF.

Mov Disord. 2016 Mar;31(3):335-43. doi: 10.1002/mds.26478. Epub 2015 Dec 21.

PMID:
26686514
50.

Assessing the role of TUBA4A gene in frontotemporal degeneration.

Dols-Icardo O, Iborra O, Valdivia J, Pastor P, Ruiz A, López de Munain A, Sánchez-Valle R, Álvarez V, Sánchez-Juan P, Lleó A, Fortea J, Blesa R, Cardona F, Baquero M, Alonso MD, Ortega-Cubero S, Pastor MA, Razquin C, Boada M, Hernández I, Gorostidi A, Moreno F, Zulaika M, Lladó A, Coto E, Combarros O, Pérez-Tur J, Clarimón J; Dementia Genetics Spanish Consortium (DEGESCO).

Neurobiol Aging. 2016 Feb;38:215.e13-215.e14. doi: 10.1016/j.neurobiolaging.2015.10.030. Epub 2015 Nov 5.

PMID:
26675813

Supplemental Content

Loading ...
Support Center